Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
The investment case for health technology in India is frequently overstated in one direction and understated in another
Revvity is positioning its technologies as a connected engine for discovery
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
Muted movement reflects consolidation phase as investors await earnings triggers
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
Subscribe To Our Newsletter & Stay Updated